Stephanie Okey is Director of Catalent, Inc.. Currently has a direct ownership of 12,635 shares of CTLT, which is worth approximately $742,053. The most recent transaction as insider was on Oct 30, 2024, when has been sold 4,663 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.6K
58.49% 3M change
58.49% 12M change
Total Value Held $742,053

Stephanie Okey Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 30 2024
BUY
Grant, award, or other acquisition
-
4,663 Added 26.96%
12,635 Common Stock
Oct 27 2023
BUY
Grant, award, or other acquisition
-
6,993 Added 46.73%
7,972 Common Stock
Aug 28 2023
BUY
Grant, award, or other acquisition
-
979 Added 50.0%
979 Common Stock

Also insider at

CRNX
Crinetics Pharmaceuticals, Inc. Healthcare
PTCT
PTC THERAPEUTICS, INC. Healthcare
ALBO
ALBIREO PHARMA, INC. Healthcare
SO

Stephanie Okey

Director
San Diego, CA

Track Institutional and Insider Activities on CTLT

Follow Catalent, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTLT shares.

Notify only if

Insider Trading

Get notified when an Catalent, Inc. insider buys or sells CTLT shares.

Notify only if

News

Receive news related to Catalent, Inc.

Track Activities on CTLT